ZYME
Zymeworks Inc.
NASDAQ · Healthcare · Biotechnology · CA
$26.57
−3.31%Forward multiples
Based on analyst estimates
- P/E forward
- 8.94x
- P/E 2026E
- 18.30x
- P/E 2027E
- 20.34x
- P/E 2028E
- 133.89x
- P/S forward
- 4.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 23.46x
- Price / sales
- 50.78x
- Price / cash flow
- -15.84x
Enterprise value
- Enterprise value
- $1.9B
- EV / sales
- 50.73x
- EV / EBITDA
- -13.46x
- EV / EBIT
- -12.11x
- Market cap
- $1.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026